Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

February 15, 2024; Volume 21,Issue 2

Editorials

  • Open Access
    Circulating cell-free mtDNA as a new biomarker for cancer detection and management
    Fan Peng, Siyuan Wang, Zehui Feng, Kaixiang Zhou, Huanqin Zhang, Xu Guo, Jinliang Xing and Yang Liu
    Cancer Biology & Medicine February 2024, 21 (2) 105-110; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0280
  • Open Access
    DNA methylation profiles in cancer: functions, therapy, and beyond
    Jinrong Zhu, Yongjie Yang, Li Li, Jiuren Tang and Rongxin Zhang
    Cancer Biology & Medicine February 2024, 21 (2) 111-116; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0403
  • Open Access
    First-line immunotherapy for advanced non-small cell lung cancer: current progress and future prospects
    Jingyi Wang and Lin Wu
    Cancer Biology & Medicine February 2024, 21 (2) 117-124; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0401

Perspectives

  • Open Access
    Deep insight into the B-cell associated tertiary lymphoid structure and tumor immunotherapy
    Jilong Yang, Jin Xu, Haotian Liu, Wanyi Xiao and Gengpu Zhang
    Cancer Biology & Medicine February 2024, 21 (2) 125-131; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0308
  • Open Access
    From dichotomy to diversity: deciphering the multifaceted roles of tumor-associated macrophages in cancer progression and therapy
    Xiumei Wang, Jun Chen and Guangshuai Jia
    Cancer Biology & Medicine February 2024, 21 (2) 132-138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0370
  • Open Access
    Perspective on new cell-free DNA technologies for early cancer detection
    Jie Li and Xun Lan
    Cancer Biology & Medicine February 2024, 21 (2) 139-143; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0159

Review

  • Open Access
    Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma
    Yang Song, Harry CH Lau, Xiang Zhang and Jun Yu
    Cancer Biology & Medicine February 2024, 21 (2) 144-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0394

Mini Review

  • Open Access
    Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis
    Yi Li, Bing Wei, Xia Xue, Hongle Li and Jun Li
    Cancer Biology & Medicine February 2024, 21 (2) 163-174; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0177

Original Article

  • Open Access
    Cancer-educated neutrophils promote lung cancer progression via PARP-1-ALOX5-mediated MMP-9 expression
    Lulu Han, Yuxin Chen, Nan Huang, Xiaowan Zhou, Yanfang Lv, Huizhong Li, Dafei Chai, Junnian Zheng and Gang Wang
    Cancer Biology & Medicine February 2024, 21 (2) 175-192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0248
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 21 (2)
Cancer Biology & Medicine
Vol. 21, Issue 2
15 Feb 2024
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorials
  • Perspectives
  • Review
  • Mini Review
  • Original Article

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire